Growing community of inventors

Toyonaka, Japan

Takayuki Kanazawa

Average Co-Inventor Count = 12.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Takayuki KanazawaAtsushi Tanaka (79 patents)Takayuki KanazawaAtsushi Tanaka (2 patents)Takayuki KanazawaTetsuya Yoshida (2 patents)Takayuki KanazawaNorio Nonomura (2 patents)Takayuki KanazawaShimon Sakaguchi (2 patents)Takayuki KanazawaHisashi Wada (2 patents)Takayuki KanazawaYujiro Kidani (2 patents)Takayuki KanazawaMitsunobu Matsumoto (2 patents)Takayuki KanazawaSatomi Shinonome (2 patents)Takayuki KanazawaKanji Hojo (2 patents)Takayuki KanazawaNaganari Ohkura (2 patents)Takayuki KanazawaAtsunari Kawashima (2 patents)Takayuki KanazawaTakayuki Kanazawa (2 patents)Atsushi TanakaAtsushi Tanaka (79 patents)Atsushi TanakaAtsushi Tanaka (49 patents)Tetsuya YoshidaTetsuya Yoshida (11 patents)Norio NonomuraNorio Nonomura (5 patents)Shimon SakaguchiShimon Sakaguchi (5 patents)Hisashi WadaHisashi Wada (3 patents)Yujiro KidaniYujiro Kidani (2 patents)Mitsunobu MatsumotoMitsunobu Matsumoto (2 patents)Satomi ShinonomeSatomi Shinonome (2 patents)Kanji HojoKanji Hojo (2 patents)Naganari OhkuraNaganari Ohkura (2 patents)Atsunari KawashimaAtsunari Kawashima (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Shionogi Company Limited (2 from 1,001 patents)

2. Osaka University (2 from 985 patents)


2 patents:

1. 11932696 - Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells

2. 10550191 - Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…